MedTrace Logo

A Study to Evaluate the Safety and Efficacy of Oral Contrast Agent for Sonography

NCT05676164 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 280

Last updated 2023-01-09

No results posted yet for this study

Summary

The goal of this clinical trial is to verify the safety and efficacy of Oral Contrast Agent for Sonography produced by Shandong Baiduo Medical Instruments Co., LTD.

Conditions

  • Unspecified Disorder of Stomach and Duodenum

Interventions

DEVICE

KANG XIAN

This product is a liquid composed of silica, stabilizer, xylitol, flavoring agent and water. The pH value of the product is 5.0 \~ 8.0, and the total heavy metal content (measured by Pb2+) is less than 10µg/ml.

DEVICE

TIAN XIA

The products are dark yellow granules made from rice, soybean, lotus root powder, orange peel, coix seed and yam.

Sponsors & Collaborators

  • Shandong Branden Med.Device Co.,Ltd

    lead INDUSTRY

Principal Investigators

  • Huixiong Xu, Dr. · Shanghai 10th People's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-31
Primary Completion
2022-08-22
Completion
2022-08-22

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05676164 on ClinicalTrials.gov